Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,854    

Indirect Shares

   247,533      
Direct Value   $43,066,843    

Indirect Value

   $21,938,850      
Total Shares   787,387      
Total Value   $65,005,693      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $22,940 Incyte Corp $895,340 Immunome Inc. $143,648 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $22,940 Incyte Corp $895,340 Immunome Inc. $143,648
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.1%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
* Premium Members only  

Records found :    852         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 24 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-02-21 4 OE $14.39 $43,170 D/D 3,000 291,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-11-01 4 OE $14.39 $57,560 D/D 4,000 292,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-12-26 4 OE $14.39 $57,560 D/D 4,000 292,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-01-14 4 OE $14.39 $57,560 D/D 4,000 292,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-02-05 4 OE $14.39 $57,560 D/D 4,000 292,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-02-14 4 OE $14.39 $57,560 D/D 4,000 292,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-02-27 4 OE $14.39 $57,560 D/D 4,000 292,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-01-08 4 OE $14.39 $86,340 D/D 6,000 294,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-12-29 4 AS $88.18 $132,270 D/D (1,500) 295,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-01-27 4 AS $85.49 $712,388 D/D (8,333) 295,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-01-28 4 AS $82.91 $690,889 D/D (8,333) 295,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-01-29 4 AS $82.67 $688,972 D/D (8,334) 295,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-02-17 4 AS $84.54 $676,320 D/D (8,000) 295,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-02-18 4 AS $85.08 $595,560 D/D (7,000) 295,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-02-19 4 AS $83.58 $585,060 D/D (7,000) 295,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-03-04 4 A $77.94 $7,794 D/D 100 295,652 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-03-11 4 AS $77.68 $543,760 D/D (7,000) 295,652 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-03-12 4 AS $77.10 $539,700 D/D (7,000) 295,652 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-03-15 4 A $0.00 $0 D/D 46,340 296,106 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-03-16 4 AS $83.26 $1,248,854 D/D (15,000) 296,106 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-03-03 4 A $0.00 $0 D/D 35,580 296,413 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-03-03 4 A $94.39 $2,832 D/D 30 296,443 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-03-09 4 AS $89.52 $895,200 D/D (10,000) 296,443 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-12-28 4 AS $88.77 $133,155 D/D (1,500) 297,052 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-03-22 4 OE $14.39 $14,390 D/D 1,000 297,106 0 -
  852  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24  25   26   27   28   29   30   31   32   33   34   35      
  Page 24 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us